# GlaxoSmithKline Capital Inc. GSK 4.5 04/15/30

GlaxoSmithKline Capital Inc. GSK 4.5 04/15/30 is a security (CUSIP 377372AP2) tracked across SEC portfolio filings. 2 registered fund positions totaling $1.4M via N-PORT as of 2026-03-31.

## Summary

- Issuer: GlaxoSmithKline Capital Inc.
- Class: GSK 4.5 04/15/30
- CUSIP: 377372AP2
- Asset category: DBT
- 13F holders: 0
- N-PORT fund positions: 2
- N-PORT value: $1.4M
- N-PORT report: 2026-03-31

## Top fund holders (N-PORT)

| Fund | Registrant | Value | % of fund |
| --- | --- | --- | --- |
| [Voya Short Duration Bond Fund](https://search.stillhousedata.com/fund/S000039383) | Voya Funds Trust | $719K | 19.36% |
| [VANGUARD BALANCED INDEX FUND](https://search.stillhousedata.com/fund/S000002560) | VANGUARD VALLEY FORGE FUNDS | $687K | 0.12% |

## More

- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/security/377372AP2.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.